Senior Clinical Research Fellow, Chief Medical Officer

A 2002 MD, PhD graduate of Columbia University’s College of Physicians & Surgeons, Dr. Dammerman has been affiliated with the HIT lab since 2002. He obtained board certification in family medicine and practiced as a hospitalist prior to joining industry full-time in 2006. Since then he has worked for a number of small and mid-sized drug and drug device companies in roles of progressively increasing responsibility.  These include Head of Medical Affairs at Therakos and Senior Director, Clinical Development at Trevena, Inc.  Dr. Dammerman is well versed in all phases (I-IV) of clinical development in industry sponsored trials as well as investigator-initiated trials, collaborative trials, and healthcare economic studies conducted both in the US and globally.  His background will enable the HIT lab to increase both the scope and rigor of its already extensive clinical trials capacity to further our mission of improving the quality of healthcare worldwide.